The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer

Summary

This is a prospective cohort study on the effect of Andrographis Paniculata (AP) on palliative management of patients with advanced or metastatic esophageal cancer. A total of 30 patients with locally advanced or metastatic squamous esophageal cancer will be recruited for the trial.

Timeline

Start

2018-03-01

Primary completion

2021-02-28

Completion

2021-06-30

Drugs

Indications